2020
DOI: 10.1053/j.gastro.2020.05.095
|View full text |Cite
|
Sign up to set email alerts
|

AGA Clinical Practice Update on Endoscopic Therapies for Non-Variceal Upper Gastrointestinal Bleeding: Expert Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
77
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 94 publications
(91 citation statements)
references
References 56 publications
1
77
0
Order By: Relevance
“…Those ulcer images requiring endoscopic therapy were further classified to determine the risk of endoscopic therapy after a review by two endoscopists. Ulcers with difficult locations such as the duodenum or the lesser curvature site or those with a big ulcer base or big visible vessels are considered high risk for endoscopic therapy as the primary endoscopic hemostasis may fail [17] and the remaining were considered low risk for endoscopic therapy.…”
Section: Patients and Data Preparationmentioning
confidence: 99%
“…Those ulcer images requiring endoscopic therapy were further classified to determine the risk of endoscopic therapy after a review by two endoscopists. Ulcers with difficult locations such as the duodenum or the lesser curvature site or those with a big ulcer base or big visible vessels are considered high risk for endoscopic therapy as the primary endoscopic hemostasis may fail [17] and the remaining were considered low risk for endoscopic therapy.…”
Section: Patients and Data Preparationmentioning
confidence: 99%
“…19,20 Various guidelines recommend to continue aspirin if started as monotherapy or in combination for secondary cardiovascular prevention. [21][22][23][24][25][26] Aspirin for primary cardiovascular prophylaxis should be stopped temporarily and if indicated can be resumed within 5 days. 25 Platelet transfusion can be considered in patients with severe UGI bleed with thrombocytopenia.…”
Section: Management Of Antiplatelet and Anticoagulantsmentioning
confidence: 99%
“…25 Platelet transfusion can be considered in patients with severe UGI bleed with thrombocytopenia. All the anticoagulants need to be stopped temporarily and can be resumed within 1 week of hemostasis 26 and can be bridged with heparin in patients with high risk of thromboembolism. Reversal of anticoagulation using vitamin K, prothrombin complex concentrate (PCC), or fresh frozen plasma (FFP), and reversal agents for direct oral anticoagulants (DOAC) should be considered in case of hemodynamic instability.…”
Section: Management Of Antiplatelet and Anticoagulantsmentioning
confidence: 99%
See 2 more Smart Citations